How to Cite
Abstract
CME is generally accepted as state of art in colon cancer surgery. However, the long-term impact of CME has not been systematically examined. That's why future studies are necessary. All patients with colon carcinomas (CME group, n = 17) referred to in St Michael Archangel multiprofile hospital, the base of TSMU from January 2012 to February 2020 were prospectively analyzed and compared with patients who underwent conventional surgery in Georgian NCC, between January 2007 and December 2012 (non-CME group, n = 70). Confirmed better results in terms of lymph node yield (CME group: 27.1 vs. non-CME group: 12.4; p < 0.001) and lymph node ratio (LNR) (CME group: 0.11 vs. non-CME group: 0.23; p < 0.001) and recurrence-free survival in favor of the CME group (CME group: n = 1 vs. non-CME group: n = 14 p=0.10)
References
Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S Standardized surgery for colonic cancer: complete mesocolic excision and central ligationtechnical notes and outcome. Colorectal Dis 2009, 11:354364
Siddiqi N, Stefan S, Jootun Robotic Comple-te Mesocolic Excision (CME) is a safe and feasible option for right colonic cancers: short and midterm results from a single-centre experience. .Surg Endosc. 2021 Jan 5. doi: 10.1007/s00464-020-08194-z. Online ahead of print.
Coffey JC, Walsh D, Byrnes KG, Hohenberger W, Heald RJ. Mesentery - a `New' organ. Emerg Top Life Sci. 2020 Sep 8;4(2):191-206.
Gao Z, Wang C, Cui Y et al. Efficacy and safety of complete mesocolic excision in patients with colon cancer: three-year results from a prospective, nonrandomized, double-blind, controlled trial. Ann. Surg. 2020; 271: 519-26.
Joseph C Kong, Swetha Prabhakaran Kay T Choy Oncological reasons for performing a complete mesocolic excision: a systematic review and meta-analysis. 2021 Jan 5. ANZ J Surg 10.1111/ans.16518. Online ahead of print.
Siani LM, Lucchi A, Berti P, Garulli G. Laparoscopic complete mesocolic excision with central vascular ligation in 600 right total mesocolectomies: safety, prognostic factors and oncologic outcome. Am. J. Surg. 2017; 214: 222-7.
Hashiguchi Y, Muro K, Saito Y et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int. J. Clin. Oncol. 2020; 25: 1-42.
Zurleni T, Cassiano A, Gjoni E et al. Surgical and oncological outcomes after complete mesocolic excision in right-sided colon cancer compared with conventional surgery: a retrospective, single-institution study. Int. J. Colorectal Dis. 2018; 33: 1-8.
Koh FH, Tan KK. Complete mesocolic excision for colon cancer: is it worth it? J. Gastrointest. Oncol. 2019; 10: 1215-21
Petz W, Ribero D, Bertani E et al. Suprapubic approach for robotic complete mesocolic excision in right colectomy: oncologic safety and short-term outcomes of an original technique. Eur. J. Surg. Oncol. 2017; 43: 2060-6.
Spinoglio G, Bianchi PP, Marano A et al. Robotic versus laparoscopic right colectomy with complete mesocolic excision for the treatment of colon cancer: perioperative outcomes and 5-year survival in a consecutive series of 202 patients. Ann. Surg. Oncol. 2018; 25: 3580-6.
Zenger S, Balik E, Bugra D Complete mesocolic excision for right colon cancer. 2019. Ann Laparosc Endosc Surg 4:70
Ozben V, Aytac E, Atasoy D, et al Totally robotic complete mesocolic excision for right-sided colon cancer. J Robot Surg 2019, 13(1):107114.
Enomoto M, Katsumata K, Kasahara K Laparoscopic middle colic artery-preserved right hemicolectomy with true D3 lymph node dissection for right-sided colon cancer: modified complete mesocolic excision.2021 Jan 6. doi: 10.1007/s00464-020-08254-4. Online ahead of print.
Agalianos C, Gouvas N, Dervenis C, et al Is complete mesocolic excision oncologically superior to conventional surgery for colon cancer? A retrospective comparative study. Ann Gastroenterol 2017 30(6):688696.
Zenger S, Aytac E, Gurbuz B, Ozben Metastasis to lymph nodes around the vascular tie worsens long-term oncological outcomes following complete mesocolic excision and conventional colectomy for right-sided colon cancer. Tech Coloproctol. 2021 Jan 5. doi: 10.1007/s10151-020-02378-4. Online ahead of print.